Relative Bioavailability of Silybin A and Silybin B From 2 Multiconstituent Dietary Supplement Formulations Containing Milk Thistle Extract: A Single-dose Study
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 40 (1) , 103-113.e1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Nutraceuticals for geriatricsJournal of Traditional and Complementary Medicine, 2015
- Similarities and Differences in Gastrointestinal Physiology Between Neonates and Adults: a Physiologically Based Pharmacokinetic Modeling PerspectiveThe AAPS Journal, 2014
- The use of natural and synthetic phospholipids as pharmaceutical excipientsEuropean Journal of Lipid Science and Technology, 2014
- Common delivery systems for enhancing in vivo bioavailability and biological efficacy of nutraceuticalsJournal of Functional Foods, 2014
- Bioavailability of Plant-Derived AntioxidantsAntioxidants, 2013
- An Assessment of Pharmacokinetics and Antioxidant Activity of Free Silymarin Flavonolignans in Healthy Volunteers: A Dose Escalation StudyDrug Metabolism and Disposition, 2013
- The Hallmarks of AgingCell, 2013
- A sensitive LC–MS/MS assay for the simultaneous analysis of the major active components of silymarin in human plasmaJournal of Chromatography B, 2012
- Evidence for differences in regioselective and stereoselective glucuronidation of silybin diastereomers from milk thistle (Silybum marianum) by human UDP-glucuronosyltransferasesXenobiotica, 2011
- Pharmacokinetics and Metabolic Profile of Free, Conjugated, and Total Silymarin Flavonolignans in Human Plasma after Oral Administration of Milk Thistle ExtractDrug Metabolism and Disposition, 2008